The ES-2 ovarian cancer causes muscle wasting in vitro and in vivo: A novel experimental model of cancer cachexia

被引：0
|
作者：
Bonetto, Andrea [1 ]
Puppa, Melissa J. [2 ]
Carson, James A. [2 ]
Zimmers, Teresa A. [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Univ S Carolina, Columbia, SC 29208 USA
来源：
CLINICAL CANCER RESEARCH | 2013年 / 19卷
关键词：
D O I：
10.1158/1078-0432.OVCA13-A6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A6
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mathematical Model of Muscle Wasting in Cancer Cachexia
    Farhang-Sardroodi, Suzan
    Wilkie, Kathleen P.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 24
  • [2] Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
    Pin, Fabrizio
    Barreto, Rafael
    Kitase, Yukiko
    Mitra, Sumegha
    Erne, Carlie E.
    Novinger, Leah J.
    Zimmers, Teresa A.
    Couch, Marion E.
    Bonewald, Lynda F.
    Bonetto, Andrea
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2018, 9 (04) : 685 - 700
  • [3] Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study
    Luan, Yi
    Zhang, Yaqi
    Yu, Seok-Yeong
    You, Mikyoung
    Xu, Pauline C.
    Chung, Soonkyu
    Kurita, Takeshi
    Zhu, Jie
    Kim, So-Youn
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (02) : 1289 - 1301
  • [4] Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia
    Xi, Qiu-Lei
    Zhang, Bo
    Jiang, Yi
    Zhang, Hai-Sheng
    Meng, Qing-Yang
    Chen, Ying
    Han, Yu-Song
    Zhuang, Qiu-Lin
    Han, Jun
    Wang, Hai-Yu
    Fang, Jing
    Wu, Guo-Hao
    ONCOLOGY LETTERS, 2016, 12 (05) : 4013 - 4020
  • [5] Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues
    Papadia, A.
    Schally, A. V.
    Seitz, S.
    Buchholz, S.
    Treszl, A.
    Szalontay, L.
    Halmos, G.
    Lucci, J. A., III
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 376 - 376
  • [6] Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia
    Vaughan, Vanessa C.
    Sullivan-Gunn, Melanie
    Hinch, Edward
    Martin, Peter
    Lewandowski, Paul A.
    PLOS ONE, 2012, 7 (09):
  • [7] Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia
    Ham, Daniel J.
    Murphy, Kate T.
    Chee, Annabel
    Lynch, Gordon S.
    Koopman, Rene
    CLINICAL NUTRITION, 2014, 33 (03) : 448 - 458
  • [8] Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
    Tsui, Kuan-Hao
    Lee, Wen-Ling
    Seow, Kok-Min
    Yang, Lin-Wei
    Wang, Shih-Yi
    Wang, Peng-Hui
    Chang, Chi-Lun
    Yen, Ming-Shyen
    Cheng, Jiin-Tsuey
    Chen, Chih-Ping
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2014, 53 (01): : 35 - 42
  • [9] Interference with Ca2+-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia
    Pin, Fabrizio
    Minero, Valerio G.
    Penna, Fabio
    Muscaritoli, Maurizio
    De Tullio, Roberta
    Baccino, Francesco M.
    Costelli, Paola
    FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [10] Management of muscle wasting in cancer-associated cachexia - Understanding gained from experimental studies
    Baracos, VE
    CANCER, 2001, 92 (06) : 1669 - 1677
12345